Biotage Reports 37-Percent Revenue Growth in Q2 | GenomeWeb
NEW YORK (GenomeWeb News) - Biotage today reported a 37-percent increase in net sales for the second quarter.
 
Net sales for the three months ended June 30 increased to SEK 128.3 million ($17.96 million) from SEK 93.5 million year over year. The growth is the result of acquisitions made in 2005, Biotage said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.